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Abstract
Background: Comparison of different protein x-ray structures has previously been made in a
number of different ways; for example, by visual examination, by differences in the locations of
secondary structures, by explicit superposition of structural elements, e.g. α-carbon atom
locations, or by procedures that utilize a common symmetry element or geometrical feature of the
structures to be compared.
Results: A new approach is applied to determine the structural changes that an antibody protein
domain experiences upon its interaction with an antigenic target. These changes are determined
with the use of two different, however comparable, sets of principal axes that are obtained by
diagonalizing the second-order tensors that yield the moments-of-geometry as well as an ellipsoidal
characterization of domain shape, prior to and after interaction. Determination of these sets of
axes for structural comparison requires no internal symmetry features of the domains, depending
solely upon their representation in three-dimensional space. This representation may involve
atomic, Cα, or residue centroid coordinates. The present analysis utilizes residue centroids. When
the structural changes are minimal, the principal axes of the domains, prior to and after interaction,
are essentially comparable and consequently may be used for structural comparison. When the
differences of the axes cannot be neglected, but are nevertheless slight, a smaller relatively invariant
substructure of the domains may be utilized for comparison. The procedure yields two distance
metrics for structural comparison. First, the displacements of the residue centroids due to
antigenic binding, referenced to the ellipsoidal principal axes, are noted. Second, changes in the
ellipsoidal distances with respect to the non-interacting structure provide a direct measure of the
spatial displacements of the residue centroids, towards either the interior or exterior of the
domain.
Conclusion: With use of x-ray data from the protein data bank (PDB), these two metrics are
shown to highlight, in a manner different from before, the structural changes that are induced in
the overall domains as well as in the H3 loops of the complementarity-determining regions (CDR)
upon FAB antibody binding to a truncated and to a synthetic hemagglutinin viral antigenic target.
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Background
Comparison of different protein x-ray structures has pre-
viously been made in a number of different ways; for
example, by visual examination, by differences in the
locations of secondary structures, by explicit superposi-
tion of structural elements, e.g. α-carbon atom locations,
or by procedures that utilize a common symmetry ele-
ment or geometrical feature of the structures to be com-
pared. This latter procedure has been utilized in
connection with the identification of the structurally con-
served residues within the core of the immunoglobulin
variable domains [1]. A singular advantage of such proce-
dure, compared with the other procedures, is that it pro-
vides additional information that relates the location of
the residues to attributes of the geometrical feature to
which these locations have been aligned or referenced. For
example, it has been pointed out that the alignment,
based on the pseudo 2-fold symmetry axis of the variable
domains of known immunoglobulin structures, provides
information about the possible structural or functional roles of
residues (italics quoted verbatim in the reference) [2].
The overall shape or distribution of the amino acid resi-
dues of a protein domain may also be considered a geo-
metric invariant of a set of structures undergoing
comparison when the differences in their global
geometries are small and involve only a minor fraction of
the residues comprising the domains. The representation
of such shape may be given by the distribution of atomic,
Cα, or residue centroid locations in three-dimensional
space. Such representation, generating an ellipsoidal char-
acterization of the shape of a domain, had previously pro-
vided useful information in connection with drug
discovery [3] and with the spatial distribution of residue
hydrophobicity within protein domains [4]. This charac-
terization of domain shape provides two spatial metrics,
one of which references the location of a residue to the
ellipsoidal principal axes of the domain and the other
which yields information detailing the proximity of a res-
idue to either the interior or exterior of the protein
domain. The present paper describes how the changes in
antibody structure that occur upon binding to an anti-
genic target are characterized by the consequent changes
of these two metrics
One limitation of the present procedure is that the unlig-
anded antibody structure (domain) is required as well as
its antibody structure (domain) in the complex. While the
Protein Data Bank (PDB) [5] has numerous antibodies
complexed with their viral or chemical targets, there are
many fewer unliganded structures listed. The number of
PDB structures satisfying our requirements is further
reduced since interest will be focused on antibody bind-
ing to an influenza viral hemagglutinin antigenic target.
Furthermore, we require 100% sequence identity between
the unliganded and complexed heavy and light chain
domains of the FAB (antibody fragment). Two PDB anti-
body structures that satisfy these requirements are anti-
body HC19 complexed with a truncated hemagglutinin
structure [6], PDB id 2VIR, and its unliganded antibody
structure [7], PDB id 1GIG; and FAB 17/9 complexed with
a peptide hemagglutinin mimetic [8], PDB id 1IFH, and
its unliganded antibody structure [9], pdb id 1HIL. Inter-
est will focus on the two distance metrics of the ellipsoidal
characterization of protein domain structure and on the
complementary information they present that describes
the structural changes that occur upon the antigenic bind-
ing of these two antibodies. Hopefully, such information
involving a different perspective from that provided previ-
ously may assist in the attempts to design synthetic vaccines
on the basis of X-ray structures of anti-body-peptide complexes
[8].
Methods
The ellipsoidal characterization of a protein domain has
been previously described [10], however, it will be useful
to indulge in a degree of redundancy to smoothly illus-
trate the appropriate extension required for the present
application. The present calculations are based upon the
residue side-chain centroids of the protein. However, as
mentioned previously the distribution of points in three-
dimensional space chosen to represent a protein structure
may well be that of the Cα coordinates, of the atomic
coordinates, or of any other set of points in space chosen
to detail protein structure.
The residue centroids are calculated with inclusion of only
the heavy atoms of the side-chain and without the back-
bone atoms. One could have included the backbone
atoms as well in calculating the residue centroids which
would yield minor modifications of the present results.
Not including the backbone atoms places the residue cen-
troids at a greater distance from the backbone and pro-
vides somewhat greater emphasis with regard to
differences in side chain location and orientation.
The distribution of residue centroid side-chain locations,
, in three-dimensional space enables the assignment of
a "center-of-the-protein",  , namely, as the centroid of
all protein residue side-chain centroids:
n is the total number of residues.
The ellipsoidal representation of protein domain shape is
obtained by diagonalizing the second-order moments-of-
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geometry tensor,  , which consists of the following ele-
ments.
Where   is the unit dyadic.
The moments-of-geometry tensor is analogous to the
moments-of-inertia tensor, however, with each point
assigned a mass of one. The diagonalization of   pro-
vides the moments-of-geometry, g1, g2, and g3.
The moments provide an ellipsoidal characterization of
protein shape.
The xp, yp, zp, are the coordinates in the frame of the ellip-
soidal principal axes with the centroid of the structure as
origin. If the magnitudes are ordered as,
g1 <g2 <g3 
the major semi-principal axis is of length, d/g1
1/2.
Each i th residue at location, xip, yip, zip, in the principal axis
frame, can be considered to reside on an ellipsoid with
major semi-principal axis of length, di/g1
1/2, namely,
For a compact globular protein, the residue with the larg-
est di can specify the ellipsoid defining a presumed protein
surface. Residues with the same di, namely, residues resid-
ing on the same ellipsoid are at the same radial fractional
distance from the protein centroid to the protein ellipsoi-
dal surface. Rewriting equation 5 as:
with
enables   to be used as a measure of the radial fractional
distance of the ith residue from the center of the protein
to the protein surface. This distance, which will be called
the ellipsoidal distance, is used in the calculations. It is
just the value of the semi-principal major axis of the ellip-
soid upon which the residue centroid is found. It provides
a more accurate characterization of the amino acid prox-
imity to the protein exterior than the radial distance from
the protein center to the residue centroid, as well as pro-
viding a distance that correlates more closely with residue
solvent accessibility [11].
To calculate the displacements of the residues in the lig-
anded compared with the unliganded structure, the calcu-
lations are performed twice; once inclusive of all residues
of the unliganded domain which we will designate by "a"
and once inclusive of all residues of the domain in the
complex which we will designate by "b".
The magnitude of the displacement of the ith residue cen-
troid of the complexed domain with respect to its location
in the unliganded domain, Di, is given by the distance
between the coordinates of the centroids with respect to
the two different sets of principal axes.
Di = [(xbip - xaip)2 + (ybip - yaip)2 + (zbip - zaip)2]1/2 
The subscript, with either an "a" or "b", designates
whether the coordinate is referenced to the principal axes
of the unliganded or of the liganded domain, respectively.
The difference or the change in the ellipsoidal distance of
the ith residue, Ei, is given by:
When the difference between the antibody structures of
the liganded and unliganded domains is minimal this
procedure will provide a relatively accurate characteriza-
tion of the displacements and changes in the ellipsoidal
distances that occur. However, if the liganded and unlig-
anded structures differ sufficiently, the calculated differ-
ences may then be anomalous. For example residues far
from the binding site should exhibit minimal displace-
ments upon complexing. If this is not observed then the
liganded and unliganded structures would be sufficiently
different and not provide principal axes that are compara-
ble and consequently appropriate to be used for structural
comparison. If, however, only a minor region or part of
the liganded and unliganded structures differs, e.g., per-
haps only differing in the vicinity of the binding site, such
difficulty may be circumvented by the choice of compara-
ble substructures to reference the displacements and the
changes in ellipsoidal distances. The substructures cho-
sen, for example, may involve the elimination of residues
that exhibit significant displacements between the lig-
anded and unliganded structures. In pursuit of such strat-
egy, after diagonalization of the tensor, all residue
locations of the substructures will be provided; however,
locations of the residues that have been eliminated in the
choice of the substructures would then have to be calcu-
lated by translating the location of these residues to the
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centers-of-geometry of each of the substructures and then
by rotating into the orientation of the principal axes of the
substructures. This procedure will be demonstrated in the
comparison between the residue locations of the 1IFH
and 1HIL pdb viral structures.
Finally, it should be noted that this strategy of referencing
structures undergoing comparison to the sets of principal
axes of relatively invariant substructures represents a more
general and inclusive strategy than referencing the struc-
tures to sets of symmetry axes, e.g., alignments based on
the pseudo 2-fold symmetry axes of the variable domains
of known immunoglobulin structures. In the present case
the invariance of the axes is a consequence of the invari-
ance of the substructures and need not be related to any
explicit structural symmetry.
Results and discussion
Calculations have been performed utilizing the x-ray
structure of a free HC19 FAB [7; pdb id 1GIG] and the
structure of the HC19 FAB in complex with the membrane
distal domain of X31 hemagglutinin ('HA-top') [6; pdb id
2VIR]. Figures 1A and 1C show the displacements and dif-
ferences in ellipsoidal distances in Angstroms of the
amino acid centroids of the N-terminal FAB heavy chain
domain of the complex, from their locations in the free or
A. The Displacements in Angstroms of the amino acid centroids from their locations in the unliganded domain of the heavy  chain (PDB file, 1GIG) to their locations in the complexed domain of the heavy chain (PDB file, 2VIR) Figure 1
A. The Displacements in Angstroms of the amino acid centroids from their locations in the unliganded domain of the heavy 
chain (PDB file, 1GIG) to their locations in the complexed domain of the heavy chain (PDB file, 2VIR). B. The Displacements 
described in A, shown on an expanded scale about the amino acid residues of greatest Displacement. C. The differences in the 
ellipsoidal distances (Differential Ellipsoidal Distances) in Angstroms of the amino acid centroids of the heavy chain domain of 
the complex (PDB, 2VIR) from their values in the uncomplexed heavy chain domain (PDB, 1GIG). D. The differences described 
in C, shown on an expanded scale about the amino acid residues showing the greatest differences. The units of displacements 
and distances are also in Angstroms in all subsequent figures.BMC Structural Biology 2007, 7:77 http://www.biomedcentral.com/1472-6807/7/77
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unliganded antibody domain. First, one notes, that aside
from the regions of amino acids that are bracketed by the
dashed lines or specifically labeled, the displacements and
differences are small, mainly less than 1 Angstrom, con-
firming that a major portion of the overall antibody struc-
ture, before and after binding is comparable. The
bracketed region spans residues PHE99 to TYR107. This
region, the region undergoing the most extensive struc-
tural modification of the antibody upon binding to the
truncated "HA top" involves the tip of the H3 CDR (com-
plementarity-determining region). It is highlighted in
white in figure 2. Figures 1B and 1D, which are expanded
views of the bracketed regions, accentuate the comple-
mentarity of the information provided by the two differ-
ent distance metrics. Note that the amino acid with the
greatest displacement, TYR102 in figure 1B, shows a dif-
ference in ellipsoidal distance in figure 1D that is approx-
imately equal to zero; whereas PHE105, which has a
displacement less than TYR102 exhibits the largest value
of differential ellipsoidal distance. Figure 3 illustrates the
reason for this difference. Comparison of figure 3A with
figure 3b shows that the structural modification of the H3
loop upon binding involves the swapping of the location
of TYR102, behind the loop shown in the unliganded
structure of figure 3A, to a location in front of the loop in
the liganded complex shown in figure 3B. While this
involves a relatively large displacement from its position
in the unliganded structure, its distance from the interior
of the heavy chain domain (to the right in the figures) is
relatively unchanged. This contrasts with the rotation of
the PHE105 six-membered ring which clearly places its
residue centroid upon complexation at a greater distance
from the interior of the heavy chain domain.
Furthermore, while figure 1A shows the ASN56 residue of
the H2 CDR loop of the N-terminal domain of the heavy
chain to exhibit only a slightly greater displacement than
the displacements of its adjacent residues, figure 1C shows
its comparative displacement towards the interior of the
N-terminal domain of the heavy chain to be enhanced
compared with those of its neighbors. This is apparently
mediated by the interaction in the complex between
ASN56 and its proximate neighbor SER157 of the "HA-
top" as shown in figure 4.
Moments of the 1GIG and 2VIR structures obtained by the
diagonalization of equation 2 differ by a few percent and
the two sets of principal coordinates yield coordinate
frames with axes alignments that differ by at most several
degrees.
Certain enhanced displacements apparently identify resi-
dues that have been spatially shifted due to crystal pack-
ing. Figure 1A shows an enhanced displacement, with
respect to the local background, of the residue GLN16 of
the heavy chain N-terminal domain. Such displacement,
clearly unrelated to antibody binding, appears to arise
from crystal packing. Residues significantly displaced,
while not in the vicinity of the region of binding and also
observed to be considerably solvent exposed in the free
state of the antibody can be so identified.
Figure 5 shows the displacements and the differential
ellipsoidal distances obtained for the amino acids of the
light chain. The ordinate scales of figures 5A and 5C have
been chosen with the same extent as those of figures 1A
and 1C. The smaller displacements and differences of the
light chain compared with those of the heavy chain high-
light the weaker binding of the antigenic epitope to the
light compared with the heavy chain. Examination of the
bound structure shows the antigenic epitope to be at a
much greater distance from the light chain than its dis-
tance from the heavy chain. Aside from the amino acids
bracketed by the dashed lines, the displacements and dif-
ferences in ellipsoidal distances are small; less than 1 Ang-
strom on average. The bracketed amino acids include
TYR94 to ASN96. A number of close distances between
the heavy atoms of the amino acid ASN96 of this group
and those of SER159 of the "HA-top" are apparently
responsible for the interactions that contribute to the
enhanced values of the displacements of this group of res-
idues. Furthermore, the lack of correspondence between
the magnitudes of the displacements and differential
ellipsoidal distances for all of the residues, and in particu-
lar for the residues TYR94 and SER95 of this set, is
observed and this once again emphasizes the complemen-
tary nature of the information provided by these two dif-
ferent spatial metrics.
The H3 CDR (complementarity-determining region) region  of the heavy chain, highlighted in white, which undergoes the  most extensive structural modification upon antibody binding  to the truncated "HA top" Figure 2
The H3 CDR (complementarity-determining region) region 
of the heavy chain, highlighted in white, which undergoes the 
most extensive structural modification upon antibody binding 
to the truncated "HA top".BMC Structural Biology 2007, 7:77 http://www.biomedcentral.com/1472-6807/7/77
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The orientation of the heavy chain residues TYR102 and PHE105 in the uncomplexed structure (1GIG) (figure 3A) and in the  complexed structure (2VIR) (figure (3B), respectively, with respect to the bulk of the heavy chain (off and to the right of the fig- ure) Figure 3
The orientation of the heavy chain residues TYR102 and PHE105 in the uncomplexed structure (1GIG) (figure 3A) and in the 
complexed structure (2VIR) (figure (3B), respectively, with respect to the bulk of the heavy chain (off and to the right of the fig-
ure).
The orientation of the residue ASN56 of the heavy chain prior to complexing (Figure 4A) with its orientation in interaction  with the SER157 residue of the "HA top" (Figure 4B) after complexing Figure 4
The orientation of the residue ASN56 of the heavy chain prior to complexing (Figure 4A) with its orientation in interaction 
with the SER157 residue of the "HA top" (Figure 4B) after complexing.BMC Structural Biology 2007, 7:77 http://www.biomedcentral.com/1472-6807/7/77
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A few words should be devoted to the relationship
between the intent of the previous X-ray studies and the
objectives of the present study. The later X-ray study [6]
had focused on the effect of two mutant antigens in induc-
ing structural distortions of the bound complex that could
be responsible for the evasion of antibody neutralization.
An earlier rigid-body docking study [12] had examined
the effect of a number of mutations upon HC19 antibody
binding. The present study does not address this issue and
has focused solely upon the 2VIR structure; namely, the
complex involving the wild type antigenic hemagglutinin
"top". The earlier study [8] involved an extensive exami-
nation of the structural differences that occur due to anti-
body binding. Differences in the binding to three different
antigenic mimetics of HA1 were examined. It was empha-
sized that the information obtained was encouraging for
attempts to design synthetic vaccines on the basis of X-ray struc-
tures of anti-body-peptide complexes [8]. It was also stated
that only by comparing the free, unliganded structure with its
complexed form is it possible to asses the extent and contribu-
tion of conformational changes to the antigen recognition proc-
ess; a statement supportive of the strategy of the present
work. Furthermore, it was stated that, Although many Fab
Structures have been determined as complexes, only a few have
also been described in their uncomplexed state; a situation
which is paralleled to this date since there are, presently,
many fewer uncomplexed immunoglobulin structures
than complexed structures. Finally, extreme differences in
the extent of the conformational adaptations in antibod-
ies as a consequence of antigenic binding had been noted
[13], and, a large conformational change observed in the H3
loop between the free and bound form [8] was found. This
large conformational change of the H3 CDR loop of the
1IFH structure contrasts significantly with the correspond-
ing change of the H3 CDR loop of the 2VIR structure. This
difference is illustrated in figure 6 by a CE (Combinatorial
Extension) superposition [14] of the H3 antibody loops
of the 2VIR and 1IFH PDB complexed structures, upon
their respective H3 loops of the1GIG and 1HIL PDB
uncomplexed structures. A similar superposition had
A. The Displacements of the amino acid centroids from their locations in the unliganded domain of the light chain (PDB file,  1GIG) to their locations in the complexed domain of the light chain (PDB file, 2VIR) Figure 5
A. The Displacements of the amino acid centroids from their locations in the unliganded domain of the light chain (PDB file, 
1GIG) to their locations in the complexed domain of the light chain (PDB file, 2VIR). B. The Displacements described in A, 
shown on an expanded scale about the amino acid residues of greatest Displacement. C. The differences in the ellipsoidal dis-
tances (Differential Ellipsoidal Distances) of the amino acid centroids of the light chain domain of the complex (PDB, 2VIR) 
from their values in the uncomplexed light chain domain (PDB, 1GIG). D. The differences described in C, shown on an 
expanded scale about the amino acid residues showing the greatest differences.BMC Structural Biology 2007, 7:77 http://www.biomedcentral.com/1472-6807/7/77
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been previously performed for the CDR loops of the anti
HIV Fab 50.1 [15]. The relatively greater distortion of the
H3 loop of 1IFH structure compared with that of 2VIR is
consistent with the idea that shape complementarity ...for the
smaller, flexible peptides can more easily achieve closer contact
with the paratope surface [16]. Such relatively large struc-
tural change of the N-terminal heavy chain domain of
the1IFH structure upon binding will be shown to require
modification of the present procedure to properly repre-
sent the observed structural changes. This provides an
example of how the substructures of a set of structures
may be selected to obtain sets of relatively invariant prin-
cipal axes to be used for structural comparison.
Figure 7 shows the displacements and differences in the
ellipsoidal distances for the N-terminal domain of the
complexed heavy chain of 1IFH with respect to the unlig-
anded heavy chain of 1HIL. It should be noted that the
offset in numbering of the abscissa with respect to the res-
idue number is due to the way the amino acid insertions
are labeled in the PDB files. The abscissa lists all of the res-
idues in a sequential numbering scheme independent of
how they are labeled in the PDB files. A comparison of fig-
ure 7A with figure 1A was initially surprising. While one
observes significant displacements of those antibody resi-
dues interacting directly with the residues of the antigenic
mimetic, one also notes that the displacements of the
amino acid residues that do not directly interact with the
antigen are greater than what had appeared in figure 1A.
For example, the mean displacement of the first 95 N-ter-
minal heavy chain amino acid residues of 1IFH-1HIL is
2.94 Angstroms with a standard deviation of 1.32 Ang-
stroms, whereas the mean displacement and standard
deviation of the first 95 N-terminal heavy chain residues
of 2VIR-1GIG are 0.84 Angstroms and 0.44 Angstroms,
respectively. For the 1IFH-1HIL comparison, this appears
to belie the original assumption that the majority of the
residues that are not interacting directly with the protein
mimetic should be minimally displaced from their loca-
tion in the unliganded structure. Such displacements of
up to or greater than 5 Angstroms are observed in figure
7A. This can occur if the two sets of principal axes chosen
for comparison are significantly rotated and/or translated
with respect to each other when referenced to a global
coordinate set of axes. Since the orientation of the axes are
obtained by diagonalizing a matrix that is quadratic in the
distance of the residues from the center-of-geometry of
the domain, a major contribution to such relative rotation
would arise from the residues that are most distant from
the geometric center of the domain and most significantly
displaced. Such correlation between the displacements
and distances from the center of the domain is shown vis-
ually in Figure 8 where the residue ellipsoidal distances
(dashed curve) of 1HIL (a relative measure of distance
from the centroid of the domain) are overlaid upon the
displacements (solid curve) shown in figure 7A.
Such difference in the orientation of the two sets of prin-
cipal axes can be significantly reduced by determining the
axes for substructures from which significantly displaced
distant residues from the center of the domain have been
eliminated. While there is a degree of freedom in the
choice of such elimination and one may be motivated to
optimize the correspondence between the two sets of
principal axes used for comparison, the substructures
presently chosen will simply involve the elimination of
only the two residues ASP99 and ASN100A from the H3
CDR loops, namely, the residues that exhibit the greatest
displacements shown in figures 7A and 7B. With the prin-
cipal axes obtained for both reduced liganded and unlig-
anded substructures one would then rotate the original
sets of residue centroids eliminated in the determination
of the substructure, into the substructure principal axis
orientations after translations to the substructure centers-
of-geometry.
Figure 9 shows the results obtained for the residues of the
heavy chain with the residues ASP99 and ASN100A
deleted from the substructures determining the principal
axes used for comparison. The displacements of residues
not directly interacting with the antigen shown in figure
9A are now reduced in magnitude compared with the
comparable displacements shown in figure 7A; namely,
the first 95 N-terminal heavy chain residue displacements
now have a mean of 1.06 Angstroms with a standard devi-
ation of 0.51 Angstroms. Figure 9B shows the greatest res-
idue displacements on an expanded scale, and these
residues, ARG97 to ASN100A, near the antigenic mimetic,
A CE (Combinatorial Extension) superposition of A. the H3  loop of the complexed 1IFH PDB structure upon the H3  loop of the uncomplexed 1HIL PDB structure Figure 6
A CE (Combinatorial Extension) superposition of A. the H3 
loop of the complexed 1IFH PDB structure upon the H3 
loop of the uncomplexed 1HIL PDB structure. B. the H3 
loop of the complexed 2VIR PDB structure upon the H3 
loop of the uncomplexed 1GIG PDB structure.BMC Structural Biology 2007, 7:77 http://www.biomedcentral.com/1472-6807/7/77
Page 9 of 12
(page number not for citation purposes)
are highlighted on the terminal loop of the H3 CDR of the
antibody shown in figure 10.
Changes in the magnitudes of the ellipsoidal distances
contrast with what had been found for the displacements.
Comparison of the figures 9C and 7C surprisingly shows
comparable ranges of the values of these changes. This is
also seen in the expanded scales of figures 9D and 7D
which detail the region of interaction and consequently of
the region of greatest change. So, one might conclude that
the ellipsoidal distances are relatively insensitive to rota-
tions of the principal axes. This is apparently a conse-
quence of the proportionality of the ellipsoidal distances
to the radial fractional distances from the center of the
domain to the ellipsoidal surface or exterior. Such propor-
tionalities are relatively unchanged as the principal axes
are slightly rotated with respect to each other. This would
be especially true for a domain approximately spherical in
shape.
A. The Displacements of the amino acid centroids from their locations in the unliganded domain of the heavy chain (PDB file,  1HIL) to their locations in the complexed domain of the heavy chain (PDB file, 1IFH) Figure 7
A. The Displacements of the amino acid centroids from their locations in the unliganded domain of the heavy chain (PDB file, 
1HIL) to their locations in the complexed domain of the heavy chain (PDB file, 1IFH). B. The Displacements described in A, 
shown on an expanded scale about the amino acid residues of greatest Displacement. C. The differences in the ellipsoidal dis-
tances (Differential Ellipsoidal Distances) of the amino acid centroids of the heavy chain domain of the complex (PDB, 1IFH) 
from their values in the uncomplexed heavy chain domain (PDB, 1HIL). D. The differences described in C, shown on an 
expanded scale about the amino acid residues showing the greatest differences.
The ellipsoidal distances (dashed) of the antibody heavy chain  amino acids (PDB id. 1HIL) overlaid upon their displacements  (solid) (PDB id. 1IFH) upon complexing Figure 8
The ellipsoidal distances (dashed) of the antibody heavy chain 
amino acids (PDB id. 1HIL) overlaid upon their displacements 
(solid) (PDB id. 1IFH) upon complexing.BMC Structural Biology 2007, 7:77 http://www.biomedcentral.com/1472-6807/7/77
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Complementary information is again provided by a com-
parison of the displacements shown in figure 9B with the
changes in ellipsoidal distances upon complexing indi-
cated by figure 9D. This comparison shows that while a
number of residues of the H3 loop are significantly dis-
placed, some move towards the domain interior of the
heavy chain while others move away. Figure 11 is ball and
stick representation of three of the residues that are signif-
icantly displaced upon complexing. Due to the severe H3
loop distortion upon binding this triplet is rotated from
an orientation in which a residue initially pointing either
up or down in figure 11A prior to complexing is reversed
in direction in figure 11B after complexing. Note, that
aside from the H3 loop distortion, the heavy chain orien-
tation has been held relatively fixed in both of the figures.
All three of these residues have, therefore, experienced a
significant displacement, as shown in figure 11B, from
their location prior to complexing. However, while,
GLU100 moves away from the center of the N-terminal
domain of the heavy chain upon binding, a rotation
about its CA-CB bond enhances the motion of the residue
The following quantities obtained after elimination of ASP99 and ASN100A from the substructures determining the principal  axes used for comparison Figure 9
The following quantities obtained after elimination of ASP99 and ASN100A from the substructures determining the principal 
axes used for comparison. A. The Displacements of the amino acid centroids from their locations in the unliganded domain of 
the heavy chain (PDB file, 1HIL) to their locations in the complexed domain of the heavy chain (PDB file, 1IFH). B. The Dis-
placements described in A, shown on an expanded scale about the amino acid residues of greatest Displacement. C. The differ-
ences in the ellipsoidal distances (Differential Ellipsoidal Distances) of the amino acid centroids of the heavy chain domain of 
the complex (PDB, 1IFH) from their values in the uncomplexed heavy chain domain (PDB, 1HIL). D. The differences described 
in C, shown on an expanded scale about the amino acid residues showing the greatest differences.
The antibody residues of the 1IFH PDB file highlighted in  white that exhibit the greatest displacements upon binding to  the antigenic mimetic Figure 10
The antibody residues of the 1IFH PDB file highlighted in 
white that exhibit the greatest displacements upon binding to 
the antigenic mimetic.BMC Structural Biology 2007, 7:77 http://www.biomedcentral.com/1472-6807/7/77
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centroids, ASP99 and ASN100A, to locations that are
respectively, nearer to or more distant from the center of
the heavy domain. All of these movements of these three
amino acids are summarized simply by the complemen-
tary information provided by the two figures, 9B and 9D.
Conclusion
A new approach, enabling comparison between different,
however, structurally related domains, has been applied
in determining the structural changes that an antibody
protein domain experiences upon its interaction with an
antigenic target. The present procedure, while analogous
to previous procedures that utilize common symmetry
elements for comparison, utilizes, instead, the sets of prin-
cipal axes of the relatively invariant global structures or
substructures of the domains undergoing comparison. An
ellipsoidal characterization of these structures yields two
spatial metrics that provide complementary information;
one, detailing the magnitude of the residue displacements
and the other; their direction of their displacement with
respect to either the domain exterior or interior. The infor-
mation provided by the present procedure should aug-
ment related information provided by more customary
procedures. Hopefully such information will contribute
to the attempts to design synthetic vaccines on the basis of X-
ray structures of anti-body-peptide complexes [8].
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